Haemonetics Corporation (HAE)
Manufactures automated blood collection systems and surgical monitoring devices for hospitals and plasma centers.
$83.03+0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+11.0%
The outlook
Analysts lean bullish on HAE, with an average target sitting roughly 4% above the current price. The stock is trading above both its 50- and 200-day moving averages, positioning it in the upper portion of its 52-week range. The overall sentiment reflects upbeat analyst views, though the trailing P/E of 40.5 reflects a premium valuation.
What’s behind the score
Analyst consensusBuy — 1.9 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range89% of the way from its 52-week low to high
Price targetAvg target +4% vs current price
Analyst price target
~12-month · 10 analysts$86.60average target+4.3% vs now
Now $83.03
Low $62.00High $104.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$3.77B
52-wk high
$87.32
52-wk low
$47.32
50-day avg
$72.31
200-day avg
$66.94
Trailing P/E
40.5